![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
October 17, 2025
A welcome to the new National Cancer Institute director, an update on the federal budget and its implications, and a look ahead to next week's Group Meeting
October 23, 2025
Now Enrolling: EA8231 Study for Patients With Bladder Cancer That Has Progressed Following Treatment
This phase 3 clinical trial is testing a new treatment approach for patients with treatment-refractory locally-advanced or metastatic urothelial cancer
October 17, 2025
Dr. Reid’s research focuses on young-onset breast cancer, hereditary breast cancer, and population-based differences in breast cancer outcomes
October 17, 2025
Summaries of two clinical trials presented at the 2025 World Conference on Lung Cancer
October 17, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
September 19, 2025
An update on the cancer research environment, a recap of the September NCAB meeting, and a preview of the fall group meeting
September 5, 2025
This clinical trial is testing a new treatment approach for patients with gastric carcinomatosis
September 19, 2025
Changes broaden eligibility for this study of how adverse life experiences alter genes, immune cells, and subsequent health outcomes
September 19, 2025
September 19, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
August 28, 2025
An open letter from the NCTN Cooperative Group Chairs to Congress on the importance of supporting robust federal funding for cancer research
August 28, 2025
This clinical trial aims to improve outcomes by utilizing novel myeloma targeting therapy to reverse kidney failure